Q1 FY27 snapshot
Announcement Date22-Jul-26
Revenue (Top Line)₹8,454 Cr
Net Profit (Bottom Line)₹444 Cr
Earnings Per Share (EPS)₹5.32
Expenses₹8,010 Cr
Net profit margin (calculated)5.3%
Dr. Reddy's Laboratories Ltd. (DRREDDY) Quarterly Results: Q1 FY27
Quick answer: Dr. Reddy's Laboratories Ltd. (NSE: DRREDDY) reported Q1 FY27 revenue of ₹8,454 Cr and net profit of ₹444 Cr, with earnings per share (EPS) of ₹5.32, announced on 22-Jul-26.
That works out to a net profit margin of about 5.3% for the quarter.
Note: figures are pulled automatically from company filings and may lag or contain gaps. Verify on NSE or BSE. Not investment advice.
How to read Dr. Reddy's Laboratories Ltd.'s Q1 FY27 results
Revenue of ₹8,454 Cr is what Dr. Reddy's Laboratories Ltd. earned before costs. Net profit of ₹444 Cr is what remained for shareholders after expenses, interest and tax. Dividing one by the other gives a net margin of about 5.3%, a quick gauge of how much of each rupee of sales is kept as profit.
New to results? Read our guide on how to read quarterly results, see the full results list or the dividend calendar.
FAQs
Dr. Reddy's Laboratories Ltd. results FAQs
What were Dr. Reddy's Laboratories Ltd.'s Q1 FY27 results?
Dr. Reddy's Laboratories Ltd. (NSE: DRREDDY) reported Q1 FY27 revenue of ₹8,454 Cr and net profit of ₹444 Cr, with earnings per share (EPS) of ₹5.32, announced on 22-Jul-26.
What is Dr. Reddy's Laboratories Ltd.'s EPS for Q1 FY27?
Dr. Reddy's Laboratories Ltd.'s earnings per share for Q1 FY27 was ₹5.32. EPS is net profit divided by the number of outstanding shares.
When did Dr. Reddy's Laboratories Ltd. announce its Q1 FY27 results?
Dr. Reddy's Laboratories Ltd. announced its Q1 FY27 results on 22-Jul-26.
What is Dr. Reddy's Laboratories Ltd.'s net profit margin?
On the reported figures, Dr. Reddy's Laboratories Ltd.'s Q1 FY27 net profit margin is about 5.3% (net profit ÷ revenue).